Penumbra Inc PEN:NYSE

RT Quote | NYSE | USD
Last | 03/04/21 EST
263.24quote price arrow down-6.05 (-2.25%)
Volume
412,798
52 week range
121.80 - 314.22

...

Loading . . .

KEY STATS

  • Open268.73
  • Day High273.20
  • Day Low253.79
  • Prev Close263.24
  • 52 Week High314.22
  • 52 Week High Date01/27/21
  • 52 Week Low121.80
  • 52 Week Low Date03/23/20
  • Market Cap9.595B
  • Shares Out36.45M
  • 10 Day Average Volume0.42M
  • Dividend-
  • Dividend Yield-
  • Beta0.27
  • 1 Year % Change48.31

RATIOS/PROFITABILITY

  • EPS (TTM)-0.44
  • P/E (TTM)-595.84
  • Fwd P/E (NTM)725.18
  • EBITDA (MRQ)-8.551M
  • ROE (MRQ)-2.79%
  • Revenue (MRQ)560.41M
  • Gross Margin (MRQ)60.34%
  • Net Margin (MRQ)-3.44%
  • Debt To Equity (MRQ)4.43%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Penumbra Inc News

QUOTE FINDER

Profile

MORE
Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization...
Adam Elsesser
Chairman
Maggie Yuen
Chief Financial Officer
Lambert Shiu
Chief Accounting Officer
Johanna Roberts
Executive Vice President
Lynn Rothman
Executive Vice President
Address
1 Penumbra
Alameda, CA
94502-7676
United States